UAE Regenerative Medicine Market to grow with a CAGR of 25.34%
Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the UAE Regenerative Medicine Market.
According to TechSci Research report, “UAE
Regenerative Medicine Market Industry
Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, UAE Regenerative Medicine Market has
valued at USD 0.13 billion in 2022 and is anticipated to witness an impressive
growth in the forecast period with a CAGR of 25.34% through 2028. This can be due to collaborations and
partnerships among leading companies with a diverse approach to merge the
expertise of individual companies and to strengthen their position in the
market.
The aging population is a significant
driver of the demand for regenerative medicine. Several factors associated with
aging contribute to the increasing interest in and utilization of regenerative
therapies. Aging is often
associated with an elevated risk of osteoarthritis and other orthopedic
conditions, leading to joint degeneration and pain. Regenerative medicine,
including stem cell therapies and tissue engineering, presents alternatives for
managing and potentially reversing the effects of such conditions. Aging can
result in a decline in the body's natural healing capacity. Regenerative
medicine interventions, such as stem cell treatments and growth factor
therapies, aim to enhance the body's regenerative abilities, facilitating more
efficient healing and tissue repair. Sarcopenia, the age-related loss of muscle
mass and strength, is a common concern among the elderly. Regenerative medicine
approaches may contribute to muscle regeneration and functional improvement,
addressing issues related to frailty and weakness.
The prevalence of neurodegenerative
disorders, such as Alzheimer's and Parkinson's disease, increases with age.
Regenerative medicine research explores interventions to repair or replace
damaged neural tissues, potentially slowing the progression of these
conditions. Aging is a significant risk factor for cardiovascular diseases.
Regenerative medicine applications, such as cardiac tissue engineering and stem
cell therapies, are being investigated for their potential to repair damaged
heart tissues and improve overall cardiac function.
Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " UAE Regenerative Medicine Market.”
In September 2023, Abu
Dhabi is set to initiate a biobank dedicated to stem cell and tissue
treatments, with a focus on employing advanced technology and scientific
methodologies for addressing over 80 diseases, encompassing conditions such as
blood disorders and cancer. The Crown Prince of Abu Dhabi has given his
endorsement to utilize human stem cells and tissues in the development of
personalized medical research. This approval was granted during a meeting of
the Abu Dhabi Executive Council. The forthcoming project aims to establish a
biobank that will facilitate the advancement of personalized medicine through
innovative treatment programs utilizing human stem cells and tissues for
medical research.
Long-term
efficacy and safety is crucial considerations and potential challenges in the
field of regenerative medicine, including in the UAE. Many
regenerative medicine therapies are relatively new, and there may be limited
long-term data available on their effectiveness and safety. This lack of
comprehensive, extended-term data poses challenges in assessing the sustained
efficacy and safety of these treatments. Regenerative medicine often involves
complex biological processes, such as stem cell differentiation and tissue
regeneration. Understanding the long-term effects of these processes on the
body and ensuring their safety over time is a continuing area of research. Interventions
in regenerative medicine, particularly those involving genetic modifications,
may carry the risk of unintended consequences over the long term. Unanticipated
effects on the treated tissues or systemic effects need to be thoroughly
investigated to ensure patient safety. Monitoring patients over an extended
period to assess the long-term efficacy and safety of regenerative medicine
treatments can be challenging. Establishing effective monitoring and
surveillance systems is crucial to identify any delayed adverse effects. The
use of stem cells, especially pluripotent stem cells, raises concerns about the
potential for tumorigenesis or the development of tumors. Ensuring that
regenerative therapies do not lead to abnormal cell growth over the long term
is a critical safety consideration.
UAE Regenerative
Medicine Market is segmented based on Type, Application, End User, and by region.
Based on the Application,
UAE Regenerative Medicine Market is segmented into Bone Graft Substitutes,
Osteoarticular Diseases, Dermatology, Cardiovascular Diseases, Others. Bone
graft substitutes are materials used in orthopedic and dental surgeries to
replace or augment natural bone tissue. These substitutes aim to promote bone
regeneration and healing in cases where bone loss or damage has occurred due to
trauma, disease, or other medical conditions. Bone graft substitutes serve as
alternatives to traditional bone grafts, which involve taking bone tissue from
one part of the patient's body (autograft) or from a donor (allograft). Bone
graft substitutes often possess osteoconductive properties, meaning they
provide a scaffold or framework for new bone growth. This promotes the
migration and attachment of bone-forming cells (osteoblasts) to facilitate the
regeneration of bone tissue. Some bone graft substitutes contain osteoinductive
factors, which stimulate the differentiation and proliferation of existing
cells into bone-forming cells. This enhances the natural bone healing process. Bone
graft substitutes are designed to be biocompatible, meaning they are
well-tolerated by the body and do not cause adverse reactions. This
characteristic is crucial for successful integration with the patient's natural
bone.
Based on Region, Abu Dhabi region held the largest share
in the UAE Regenerative Medicine Market.
The active involvement of the
government in promoting regenerative medicine through funding, incentives, and
strategic initiatives can significantly impact the market dynamics. Abu Dhabi
is a hotspot for clinical trials and innovative research in regenerative
medicine, it could attract attention and investment, fostering a dominant
market presence. The availability of educational and training programs in
regenerative medicine can contribute to the development of a skilled workforce,
attracting professionals to the region.
Some of the major companies operating in
the UAE Regenerative
Medicine Market include:
- Abu Dhabi
Stem Cells Centre
- Bioscience
Clinic Middle East
- The RegeneSpine
Regenerative Spine and Joint Institute
- Novomed
UAE
- FIFA
Medical Center of Excellence
Download free Sample Report
Customers
can also request 10% free customization on this report.
“Certain areas,
particularly in Dubai, are projected to exert significant demand for Regenerative
Medicine. The growth in the competitive landscape and the presence of
well-established companies in the market, committed to enhance the overall
wellbeing of people each year, are expected to contribute to a remarkable
growth of the UAE Regenerative Medicine Market in the forecast period,"
said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based Global management consulting firm.
UAE Regenerative
Medicine Market by Type (Cell Therapy, Gene Modification, Tissue Engineering,
Others), By Application (Bone Graft Substitutes, Osteoarticular Diseases,
Dermatology, Cardiovascular Diseases, Others), By End User (Academic,
Commercial), By Region, By Competition Forecast & Opportunities, 2018-2028F has evaluated the future growth potential of UAE
Regenerative Medicine Market and provides statistics & information on
market size, structure, and future market growth. The report intends to provide
innovative market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in UAE Regenerative
Medicine Market.
Contact
Mr. Ken
Mathews
Techsci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
M:
+13322586602
Email: [email protected]
Website: https://www.techsciresearch.com